UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000040292 |
|---|---|
| Receipt number | R000045971 |
| Scientific Title | The efficacy of acute phase intervention in elderly patients with mild trauma on muscle mass maintenance and muscle catabolism biomarker : randomized controlled trial |
| Date of disclosure of the study information | 2020/05/02 |
| Last modified on | 2021/09/26 10:37:10 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
The efficacy of acute phase intervention in elderly patients with mild trauma on muscle mass maintenance and muscle catabolism biomarker : randomized controlled trial
Acronym
The efficacy of acute phase intervention in elderly patients with mild trauma on muscle mass maintenance and muscle catabolism biomarker : randomized controlled trial
Scientific Title
The efficacy of acute phase intervention in elderly patients with mild trauma on muscle mass maintenance and muscle catabolism biomarker : randomized controlled trial
Scientific Title:Acronym
The efficacy of acute phase intervention in elderly patients with mild trauma on muscle mass maintenance and muscle catabolism biomarker : randomized controlled trial
Region
| Japan |
Condition
Condition
elderly patients admitted with mild trauma
Classification by specialty
| Emergency medicine |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
Evaluation of efficacy of acute phase intervention on muscle mass change and physical function
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
femoral muscle volume change from day 1 through 14
Key secondary outcomes
Chage of Barthel Index and lower leg circumference from day1 through 14
N-titin level of days 1 and 3
Base
Study type
Interventional
Study design
Basic design
Parallel
Randomization
Randomized
Randomization unit
Individual
Blinding
Open -no one is blinded
Control
Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
YES
Concealment
Intervention
No. of arms
2
Purpose of intervention
Treatment
Type of intervention
| Food |
Interventions/Control_1
Nutritional supplement containing HMB are given to intervention group twice a day for 14 days, while providing adequate nutrition and early rehabilitation during hospitalization.
Interventions/Control_2
Nutritional supplement without HMB are given to the control group twice a day for 14 days, while providing adequate nutrition and early rehabilitation during hospitalization.
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 70 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Patients admitted to the emergency department for trauma with ISS <16
Patients expected to be hospitalized for 3 days or more
Patients who have obtained consent from the person or a representative
Key exclusion criteria
Non dialysis patients with Cre >3
Patients with anuria
Other patients who are determined to be inappropriate as subjects by the principal investigator
Target sample size
50
Research contact person
Name of lead principal investigator
| 1st name | Hidehiko |
| Middle name | |
| Last name | Nakano |
Organization
Hitachi General Hospital
Division name
Department of Emergency and Critical Care Medicine
Zip code
317-0077
Address
2-1-1, Jonancho, Hitachi, Ibaraki, Japan
TEL
0294231111
be.rann1988jp@gmail.com
Public contact
Name of contact person
| 1st name | Hidehiko |
| Middle name | |
| Last name | Hidehiko |
Organization
Hitachi General Hospital
Division name
Department of Emergency and Critical Care Medicine
Zip code
3170077
Address
2-1-1, Jonancho, Hitachi, Ibaraki, Japan
TEL
0294231111
Homepage URL
be.rann1988jp@gmail.com
Sponsor or person
Institute
Department of Emergency and Critical Care Medicine, Hitachi General Hospital
Institute
Department
Personal name
Funding Source
Organization
The General Insurance Association of Japan
Organization
Division
Category of Funding Organization
Non profit foundation
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Hitachi General Hospital Institutional Review Board
Address
2-1-1, Jonancho, Hitachi, Ibaraki, Japan
Tel
0294231111
hitachi.chiken.ha@hitachi.com
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2020 | Year | 05 | Month | 02 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2019 | Year | 09 | Month | 11 | Day |
Date of IRB
| 2019 | Year | 10 | Month | 15 | Day |
Anticipated trial start date
| 2019 | Year | 11 | Month | 01 | Day |
Last follow-up date
| 2020 | Year | 12 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2020 | Year | 05 | Month | 02 | Day |
Last modified on
| 2021 | Year | 09 | Month | 26 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045971
